Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...I remember when the Supreme Court was just about to overturn the Roe v Wade abortion ruling in 2022. I spoke to the CEO of a large American business....
...Rosalind Brewer has abruptly stepped down as chief executive of Walgreens Boots Alliance after two and a half years when the US-listed pharmacy group’s valuation halved and the group abandoned a planned...
...In 2020, Pfizer spun off its generics business Upjohn, combining it with Mylan to form Viatris, while Johnson & Johnson, GSK, Pfizer and Novartis have all shed their consumer health businesses selling over-the-counter...
...Johnson & Johnson reported a first-quarter loss as it booked a $6.9bn charge linked to its proposal to settle tens of thousands of legal claims related to allegations its talcum powder caused cancer....
...Shares of Kenvue, the consumer arm of healthcare giant Johnson & Johnson, jumped on their first day of trading after an upsized initial public offering that marked the biggest US listing in almost 18 months...
...J&J had attempted to shield Kenvue from most of the tens of thousands of talc claims already filed against the group....
...Risk management Winner: Johnson & JohnsonOriginality: 8; Leadership: 9; Impact: 9; Total: 26The litigation team in Asia-Pacific designed a digital system for the pharmaceutical business to improve its management...
...Then, in January, as part of its plan to break itself up into three pieces and then to disappear as a conglomerate, GE spun-off 80.1 per cent of its healthcare division as GE HealthCare Technologies, Inc...
...A US appeals court has dismissed a bankruptcy petition filed by a unit of Johnson & Johnson, upending the healthcare company’s attempt to resolve billions of dollars of legal claims from customers alleging...
...Johnson & Johnson has agreed to buy cardiovascular technology group Abiomed for $16.6bn, including debt, a sign that mega dealmaking remains robust in the US despite geopolitical and economic uncertainty...
...Additional reporting by Andrew Edgecliffe-Johnson...
...A coalition of ethical investors have asked Johnson & Johnson, Merck, Pfizer, Eli Lilly, Gilead, Amgen, Regeneron, Bristol Myers Squibb and AbbVie to publish a report on the process they follow when applying...
...The US billionaire’s investment group Eldridge led a $600mn debt raise for crypto conglomerate Digital Currency Group last November....
...Rauner continued to lead the remaining firm, which was renamed GTCR and mostly focused on midsized buyouts in financial services, healthcare, business services and technology....
...Johnson & Johnson announced in November it had struck a deal to acquire cardiovascular technology group Abiomed for $16.6bn, while Pfizer said in May it had agreed to buy US biotech Biohaven Pharmaceuticals...
...group Johnson & Johnson, which last year utilised a similar but slightly different bankruptcy scheme, known as the “Texas two-step”, in a bid to shield itself from almost 40,000 claims that its baby talcum...
...But now, he said, Zahawi may have finally “flown a little too close to the sun”. Zahawi was born in 1967 into an influential Kurdish family....
...Square Hospitality Group, called it “appalling and unfathomable”....
...Johnson & Johnson said it was negotiating partnership deals with two Chinese companies as it taps into a biotech boom in the country driven by a surge in private investment and government support, according...
...Johnson & Johnson is to spin off its consumer products division, best known for Band-Aids and baby shampoo, as the world’s largest healthcare company seeks to focus on pharmaceuticals and medical devices...
...Johnson & Johnson has finally decided to let shareholders do their own portfolio diversification. The world’s largest healthcare company plans to split itself in two....
...Johnson & Johnson must seize its “golden moment” and break up, outgoing chief executive Alex Gorsky has told investors at the world’s biggest healthcare company....
...It is almost two months since the Medicines and Healthcare products Regulatory Agency, the UK regulator, ruled the paediatric Covid vaccine made by BioNTech and Pfizer was safe and effective....
International Edition